Radiation dose escalation in stage III non-small-cell lung cancer.

Radiation dose escalation in stage III non-small-cell lung cancer.

For patients with stage III non-small-cell lung cancer with unresectable or inoperable tumors, definitive chemoradiotherapy is often utilized. Historically, local control and overall survival rates have been poor. In an effort to improve local control, new chemotherapeutic agents in combination wi...

Full description

Bibliographic Details
Main Authors:	William Thomas Sause, Breanne eTerakedis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-11-01
Series:	Frontiers in Oncology
Subjects:	Radiation lung cancer Dose Escalation
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2011.00047/full

Similar Items

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
by: Skinner Heath D, et al.
Published: (2013-01-01)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
by: Qin Zhang, et al.
Published: (2022-01-01)

Radiation treatment planning with embedded dose escalation
by: William T. Hrinivich, et al.
Published: (2019-08-01)

Radiation Dose Escalation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma
by: Wataru Takenaka, et al.
Published: (2020-06-01)

Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer
by: Takaya Inagaki, et al.
Published: (2022-02-01)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
by: Franz Zehentmayr, et al.
Published: (2020-06-01)

Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
by: Raphael Bodensohn, et al.
Published: (2024-03-01)

Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre
by: Vincent Khoo, et al.
Published: (2011-09-01)

A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma
by: Karthik K. Ramesh, et al.
Published: (2023-02-01)

Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer
by: Lea Hoppen, et al.
Published: (2023-02-01)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
by: Vittorio eDonato, et al.
Published: (2013-11-01)

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation  with Concurrent Twice-daily Radiotherapy for Patients  with Limited-stage Small Cell Lung Cancer
by: Jing YOU, et al.
Published: (2017-01-01)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
by: Hanna Grzbiela, et al.
Published: (2023-11-01)

A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma
by: Gregory Vlacich, et al.
Published: (2021-09-01)

Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States
by: Jashin J. Wu, et al.
Published: (2023-12-01)

A Meta-Analysis and Review of Radiation Dose Escalation in Definitive Radiation Therapy between Squamous Cell Carcinoma and Adenocarcinoma of Esophageal Cancer
by: Yu Liou, et al.
Published: (2024-02-01)

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer
by: Ma Li, et al.
Published: (2019-03-01)

What does a modified-Fibonacci dose-escalation actually correspond to?
by: Penel Nicolas, et al.
Published: (2012-07-01)

Dose escalation (81 Gy) with image-guided radiation therapy and volumetric-modulated arc therapy for localized prostate cancer: A retrospective preliminary result
by: Sheng-Yao Huang, et al.
Published: (2020-01-01)

Dosimetric Comparison of 3D Conformal Conventional Radiotherapy versus Intensity-Modulated Radiation Therapy both in Conventional and High Dose Radiation for Prostate Carcinoma
by: Azza Nasr, et al.
Published: (2016-06-01)

Clinical audit of dose-escalated radical radiotherapy for advanced cervical carcinoma using a pragmatic protocol (3 fractions of 8 Gy HDR brachytherapy)
by: Jyotirup Goswami, et al.
Published: (2021-08-01)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2018-11-01)

Dose escalation guided by 18F-FDG PET/CT for esophageal cancer
by: Bingjie Fan, et al.
Published: (2021-06-01)

Sex differences in high opioid dose escalation among Malaysian patients with long term opioid therapy
by: Zin CS, et al.
Published: (2019-04-01)

Safety rules for the construction and installation of escalators and passenger conveyors
by: 8096 British Standards Institution

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
by: Han Sun, et al.
Published: (2018-12-01)

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
by: Renzo Mazzarotto, et al.
Published: (2020-12-01)

Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report
by: N. V. Marinichenko, et al.
Published: (2020-07-01)

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis
by: Ruby Sharma, et al.
Published: (2015-01-01)

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results
by: Shuiwang Qing, et al.
Published: (2021-10-01)

Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
by: Yosef Landman, et al.
Published: (2021-01-01)

Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study
by: B. Salas, et al.
Published: (2024-03-01)

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
by: Takuro Kainuma, et al.
Published: (2019-09-01)

Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer
by: Simon Boeke, et al.
Published: (2022-11-01)

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?
by: Xiaojuan Lv, et al.
Published: (2022-10-01)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
by: Sebastian Zschaeck, et al.
Published: (2018-12-01)

DW-MRI-Guided Dose Escalation Improves Local Control of Locally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
by: Huang Y, et al.
Published: (2020-05-01)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
by: Wei-Hsien Hou, et al.
Published: (2017-01-01)

Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
by: Yue Song, et al.
Published: (2023-06-01)

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
by: Taketo Suzuki, et al.
Published: (2019-02-01)